Clinical Trials Logo

Infection clinical trials

View clinical trials related to Infection.

Filter by:

NCT ID: NCT03750162 Completed - Clinical trials for Root Canal Infection

Bacteria Elimination in Retreatment Cases Using Different Disinfection Techniques

Start date: February 1, 2017
Phase: N/A
Study type: Interventional

Nonsurgical root canal retreatment may become essential when the initial endodontic treatment fails because of the persistent intracanal or extracanal infections.It has been stated that the one of the main cause of posttreatment disease is the persistent or reintroduced microorganism such as enterococcus faecalis. Supplementary disinfection techniques such as irrigation agitation methods can help elimination of bacteria from root canal systems. The aim of this in vivo study was to compare the effect of passive ultrasonic irrigation, manual dynamic activation and photodynamic therapy in reducing bacterial load in endodontic retreatment cases with periradicular lesion by using polymerase chain reaction (PCR)in a single visit root canal treatment.

NCT ID: NCT03748992 Completed - Clinical trials for Nontuberculous Mycobacterium Infection

A Proof of Concept Study of Inhaled Nitric Oxide for Adults With Pulmonary Non-Tuberculous Mycobacterial Infection

Start date: January 28, 2019
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of open-label exposure of gNO in patients with NTM lung disease. Subjects will receive the study drug by inhaling through a nasal mask. Subjects will be treated for 3 weeks (5 days per week) and followed monthly for 3 months.

NCT ID: NCT03746327 Not yet recruiting - Clinical trials for Prostheses Infection

Efficacy and Tolerance of 4 Weeks of Tedizolid in Prosthetic Joint Infections Treated With Implant Removal

PROTEDI
Start date: March 1, 2020
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy of 4 weeks of 200 mg/24h of tedizolid for prosthetic join infections caused by tedizolid susceptible microorganisms treated with implant removal in one or two stages at 6 months of followup after stopping tedizolid treatment.

NCT ID: NCT03741322 Completed - Clinical trials for Respiratory Tract Infections

A 24 Month Observational Study of Infants 3-24 Months, Who Suffer an Acute Episode of Respiratory Infection and Wheezing Illness

BIOPA
Start date: December 12, 2018
Phase:
Study type: Observational

This study will identify infants between the age of 3 and 24 months of age who are experiencing one of their first acute respiratory infections with confirmed wheezing. Infants who are also confirmed to be wheezing and whose caregiver signs consent will be enrolled from a primary care clinic, emergency room or hospital.

NCT ID: NCT03740802 Completed - Infection Clinical Trials

Hypophosphatemia as a Predictor in Surgical Resuscitation Sepsis

Start date: January 26, 2018
Phase:
Study type: Observational

Retrospective study in the surgical intensive care unit of the Brest Teaching Hospital (France) during a 6-months period (January 2015 -May 2015) to study the independent association between hypophosphatemia and 28-day infection.

NCT ID: NCT03736421 Suspended - Septic Shock Clinical Trials

Observational Study to Evaluate Peripheral IntraVenous Analysis (PIVA) in Euvolemic, Hypovolemic, and Hypervolemic Emergency Department Patients

PIVA
Start date: November 10, 2018
Phase:
Study type: Observational

The overall goal of this multicenter project is to characterize the expected normal range of Peripheral IntraVenous Volume Analysis (PIVA) values during a euvolemic state, and how those ranges may be altered by comorbidities; the relationship between PIVA and intravenous volume administration during resuscitation of infected patients with presumed hypovolemia; and, the relationship between PIVA and volume decreases during diuresis in acute heart failure patients with hypervolemia.

NCT ID: NCT03732365 Not yet recruiting - Non-healing Wound Clinical Trials

Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds

Start date: February 1, 2019
Phase: Phase 2
Study type: Interventional

This is a randomized study to compare the safety and efficacy of a single dose of up to 2 grams of cefazolin administered using a new drug delivery method called Ultrasonic Drug Delivery (UDD), combined with standard of care (SOC) antibiotic therapy, oral or IV, compared to standard of care (SOC) antibiotic therapy alone, in treating chronic wounds with skin and soft tissue infection, containing gram-positive pathogens, in lower extremities.

NCT ID: NCT03730766 Recruiting - Clinical trials for Helicobacter Pylori Infection

Analysis of the Impact of Helicobacter Pylori on Salivary Microbiome in Adults

Start date: August 1, 2018
Phase: Phase 4
Study type: Interventional

Helicobacter pylori (H. pylori), a bacteria transmitted from human to human through upper digestive tract as well as fecal-oral transmission, had infected more than half of people around the world. However, the quantity of H. pylori in oral cavity and its influence on oral microbiota remains to be unclear. The aim of the present study was to examine the effects of H. pylori infection as well as its eradication on oral microbiota.

NCT ID: NCT03728608 Completed - Infection Clinical Trials

Optimal Feeding Tube Dwell Time in VLBW Infants to Reduce Feeding Tube Contamination

Start date: May 10, 2017
Phase: N/A
Study type: Interventional

The study team will determine whether a decreased feeding tube dwell time will reduce feeding tube contamination

NCT ID: NCT03728413 Recruiting - RSV Infection Clinical Trials

The Impact of Age on Adaptive Immunity in Adults Infected With Respiratory Syncytial Virus

INFLAMMAGE
Start date: March 5, 2019
Phase: N/A
Study type: Interventional

This study will for the first time systematically investigate the immune responses in an elderly cohort challenged with a well-defined RSV inoculum. With a global aging population and continuing difficulties in generating vaccines that can reliably induce protective immunity in the elderly, these data will indicate the targets at which development of vaccines against RSV and other infections should be directed.